Dysregulated B cells are central to many hematologic malignancies and autoimmune diseases, but current B cell-targeted therapies often fail to translate binding into effective signaling. Here, we present CD20 EryPatch, a living dynamic cellular patch that co-o... ...

请注册登录后继续浏览